These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6823693)

  • 21. Idarubicin-anti-CD3: a new immunoconjugate that induces alloantigen-specific tolerance in mice.
    Mottram PL; Han WR; Murray-Segal LJ; Mandel TE; Pietersz GA; McKenzie IF
    Transplantation; 1997 Sep; 64(5):684-90. PubMed ID: 9311703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of the immunogenicity of fetal mouse pancreas allografts by organ culture in 90 percent oxygen.
    Collier SA; Mandel TE
    Transplantation; 1983 Sep; 36(3):233-7. PubMed ID: 6412403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of murine thyroid allograft survival after 16 to 20 hours' organ culture.
    Moreland AF; Müllbacher A
    Transplantation; 1987 Mar; 43(3):417-21. PubMed ID: 2950618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens.
    Shimomura K; Hardy MA; Oluwole SF
    Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo.
    Bingaman AW; Ha J; Durham MM; Waitze SY; Tucker-Burden C; Cowan SR; Pearson TC; Larsen CP
    Transplantation; 2001 Oct; 72(7):1286-92. PubMed ID: 11602857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T-cells.
    Grazia TJ; Plenter RJ; Doan AN; Kelly BP; Weber SM; Kurche JS; Cushing SO; Gill RG; Pietra BA
    Transplantation; 2007 Jun; 83(11):1449-58. PubMed ID: 17565318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.
    Hu H; Zhu X; Joshi S; Lu L; Xia CQ; Patel JM
    PLoS One; 2015; 10(5):e0124705. PubMed ID: 25933390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New method for thyroid transplantation across major histocompatibility complex barriers using allogeneic bone marrow transplantation.
    Lee S; Sugiura K; Nagahama T; Iwai H; Yasumizu R; Yamashita T; Ikehara S
    Transplantation; 2001 Sep; 72(6):1144-9. PubMed ID: 11579314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent.
    Coulombe M; Yang H; Wolf LA; Gill RG
    J Immunol; 1999 Mar; 162(5):2503-10. PubMed ID: 10072489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
    Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
    Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.
    Nishihara M; Gotoh M; Ohzato H; Ohta Y; Luo Z; Dono K; Umeshita K; Sakon M; Monden M; Yagita H; Okumura K; Miyasaka M
    Transplantation; 1997 Oct; 64(7):965-70. PubMed ID: 9381542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H-2 I-region encoded targets in allograft rejection.
    Gose JE; Bach FH
    J Exp Med; 1979 May; 149(5):1254-9. PubMed ID: 448286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of thyroid allograft survival following organ culture. Alteration of tissue immunogenicity.
    Hullett DA; Landry AS; Leonard DK; Sollinger HW
    Transplantation; 1989 Jan; 47(1):24-7. PubMed ID: 2911873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The reversal of diabetes by pancreatic islet transplantation.
    Prowse SJ; Lafferty KJ; Simeonovic CJ; Agostino M; Bowen KM; Steele EJ
    Diabetes; 1982 Aug; 31 Suppl 4():30-8. PubMed ID: 6819962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplantation tolerance to rat cardiac and islet allografts by posttransplant intrathymic inoculation of soluble alloantigens.
    Ohajekwe OA; Chowdhury NC; Fiedor PS; Hardy MA; Oluwole SF
    Transplantation; 1995 Nov; 60(10):1139-43. PubMed ID: 7482722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
    Yu S; Nakafusa Y; Flye MW
    Surgery; 1994 Aug; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.